Antiemetics
High-yield Verified · Jul 2026Prototype: ondansetron
Antiemetics are a class of medications used to treat chemotherapy-induced nausea and vomiting.
The 5-HT3 receptor antagonists (setrons, stem -setron) are the workhorse antiemetics. Other classes (D2, NK1, antihistamines) act at different sites — learn where each one works.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 What actually triggers vomiting — the serotonin signal
Vomiting is a reflex, coordinated by a "vomiting center" in the brainstem that receives inputs from several sources: a chemical-sensing area called the chemoreceptor trigger zone (CTZ / area postrema) that samples the blood, the gut via the vagus nerve, the inner ear (motion), and higher brain centers (sights, smells, anticipation). Different antiemetics work by silencing different inputs — which is why the right drug depends on *why* the patient is nauseated.
For the biggest triggers — chemotherapy, radiation, and surgery — the culprit signal is serotonin (5-HT). These insults damage the gut lining and make enterochromaffin cells in the gut dump serotonin, which fires 5-HT3 receptors on the vagal afferent nerves in the gut wall; that signal travels up the vagus to the brainstem and also acts on 5-HT3 receptors centrally in the CTZ. The setrons block those 5-HT3 receptors at both ends — peripherally in the gut (the predominant site) and centrally — cutting the emetic signal off at its source.
02 One vomiting center, several drug classes — know the map
Because so many inputs feed the vomiting center, the antiemetics are best learned as a map of sites. The setrons (5-HT3) own chemo, radiation, and post-op nausea. Dopamine D2 antagonists — metoclopramide, prochlorperazine, promethazine — block the CTZ (metoclopramide also speeds gastric emptying). NK1 (substance-P) antagonists, the -pitants (aprepitant), are added to setrons for the most emetogenic chemo. Antihistamines and anticholinergics (meclizine, scopolamine) target the inner-ear/motion pathway — note the setrons are useless for motion sickness because that route isn’t serotonin-driven. Dexamethasone and cannabinoids round out chemo regimens.
A practical detail that follows from the pharmacology: setrons work best given prophylactically — before the emetogenic stimulus (before chemo, before the end of surgery) — because it is far easier to block the signal than to shut down vomiting already in full swing. Within the class, palonosetron is second-generation with a long half-life (~40 h), useful for *delayed* chemo nausea; and dolasetron’s IV form was pulled for chemo use over QT concerns, which is the perfect segue to the class’s signature risk.
03 Why the QT warning follows — and the 32 mg story
The signature danger of the setrons is on the heart: they can prolong the QT interval, and ondansetron does this in a dose-dependent way. A longer QT means the ventricles take longer to reset electrically, which can degenerate into Torsades de Pointes, a life-threatening arrhythmia. The risk climbs with higher doses, with other QT-prolonging drugs, and with low potassium or magnesium — which is exactly why nurses correct electrolytes before dosing and are cautious in patients with congenital long-QT syndrome.
This isn’t theoretical. After a thorough-QT study, the FDA found that a single 32 mg IV dose of ondansetron prolonged the QT enough to be unsafe, and in 2012 that 32 mg IV dose was removed from the market — the maximum single IV dose is now 16 mg. (Oral dosing was not changed.) A second thing to know: setrons add to the body’s serotonin load, so combined with SSRIs, SNRIs, or MAOIs they carry a labeled risk of serotonin syndrome. Despite these real warnings, the setrons carry no boxed warning, and their formal contraindications are just two: apomorphine (profound hypotension) and hypersensitivity.
Drug names
Indications
- Chemotherapy-induced nausea & vomiting (CINV) — including delayed CINV (palonosetron)
- Radiation-induced nausea & vomiting
- Postoperative nausea & vomiting (PONV) — prophylaxis before end of surgery
- Off-label: gastroenteritis, refractory nausea of pregnancy (specialist decision)
Mechanism of action
5-HT3 (serotonin-3) receptor antagonists competitively block 5-HT3 receptors at two sites: peripherally on vagal afferent nerve terminals in the GI tract (the predominant action) and centrally in the chemoreceptor trigger zone/area postrema. Chemotherapy, radiation, and surgery cause gut enterochromaffin cells to release serotonin, which would otherwise fire these receptors and trigger the emetic reflex; blocking them interrupts the signal at its source.
Therapeutic effects — what you'll see working
Prevention beats rescue: given before chemo, radiation, or the end of surgery, setrons stop the emetic signal before it builds. Judge success by the absence or marked reduction of nausea and vomiting episodes.
- Prevention of chemo/radiation nausea & vomiting
- Blocking the 5-HT3 receptors that gut serotonin would fire prevents the acute wave of nausea and vomiting after emetogenic chemo or radiation — most effective when given before treatment. Success is simply the patient not vomiting.
- Prevention of postoperative nausea & vomiting
- A dose timed near the end of surgery blocks the emetic signal from anesthesia and the procedure, reducing PONV in the recovery period — a common, targeted use of a single IV dose.
- Control of delayed nausea (palonosetron)
- Palonosetron’s long half-life (~40 h) and high receptor affinity extend coverage into the delayed phase (days 2–5) of chemo nausea, where shorter-acting setrons fall short.
Adverse effects
Most setron patients get only a headache or constipation. The one thing not to miss is the cardiac risk — dose-dependent QT prolongation (ondansetron) worsened by low K⁺/Mg²⁺ and other QT drugs — plus additive serotonin syndrome. The setrons carry no boxed warning; the dopamine-antagonist antiemetic metoclopramide (mapped above) is the exception — it carries a tardive-dyskinesia boxed warning (below).
Interactions
Contraindications
Only two are formal contraindications (apomorphine, hypersensitivity); congenital long-QT is a strong "avoid" caution rather than an absolute bar, and the QT-drug/electrolyte cautions are what nursing acts on.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Antiemetics used for?
How do Antiemetics work?
What are the serious side effects of Antiemetics?
See also
Irreversibly shut off the stomach’s acid pump — the most powerful acid suppressors. Take before the first meal; think about long-term effects and the clopidogrel interaction.
Block the histamine (H2) arm of acid secretion — milder and faster than PPIs but shorter-acting and prone to tolerance. Famotidine is now the mainstay; cimetidine has many interactions.
Promote elimination by several distinct mechanisms. The universal nursing rule: rule out bowel obstruction before giving any laxative.
Neutralize stomach acid for fast, short heartburn relief. Separate from other drugs; mind the bowel effects.
Slow the gut to control diarrhea — but rule out infection first. High-dose loperamide is cardiotoxic.
Locally acting anti-inflammatories that induce and maintain remission in inflammatory bowel disease. Sulfasalazine’s sulfa half drives its side effects.
Sources
- Ondansetron injection — QT/Torsades warning, apomorphine contraindication, 16 mg max single IV dose (FDA label) — FDA / DailyMed
- FDA Drug Safety Communication — 32 mg single IV ondansetron dose removed (QT prolongation), Dec 2012 — U.S. FDA
- Antiemetics — Selective 5-HT3 Antagonists — mechanism, sites of action & adverse effects — StatPearls (NCBI)
- Ondansetron — indications, dosing & patient teaching — MedlinePlus (NLM)
- Metoclopramide — tardive-dyskinesia boxed warning, 12-week limit — StatPearls (NCBI)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.